dorsaVi (ASX:DVL) is walking around with an impressive update on the commercialisation of its movement products

dorsaVi (ASX:DVL) is walking around with an impressive update on the commercialisation of its movement products. The company is rapidly growing its UK and US sales teams with 5 and 3 appointments in each market. In the OH&S space, one insurer is paying for DVL to do a workplace study at a client who has escalating OH&S claims. And the company has a whole bunch of new products coming on stream with a specific module to assess running going live this week and expected to be soft-launched at 15 Melbourne physio clinics over the next few months. The company expects physios will be able to charge $150-$250 for a running assessment which is not bad given most of the time the client is away running. I don't think it will be long before the medical market start to see DVL's products as a source of revenue rather than a cost.